BMS Rollover (CA2098TT)

Clinical Trial Grant

Duke Scholars

Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

December 9, 2019

End Date

December 19, 2024

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

December 9, 2019

End Date

December 19, 2024